Speech therapy practices provide diagnostic and treatment services for communication disorders including articulation, language delays, stuttering, voice disorders, and dysphagia across pediatric, adult, and geriatric populations. The industry is driven by growing demand from early childhood developmental screening mandates, aging populations with neurological conditions, and expanding autism and developmental disability diagnoses. Practices typically generate revenue through a combination of private insurance, Medicaid, school district contracts, and direct-pay patients.
Who buys these: Healthcare-focused entrepreneurs, private equity-backed therapy platform roll-ups, licensed speech-language pathologists (SLPs) seeking ownership, multi-specialty therapy group operators, and strategic acquirers consolidating pediatric or adult rehabilitation services
3.5–6×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Recession Resistant
Essential service
Typically targeting practices with $1M–$5M in revenue, EBITDA margins of 15–30%, at least 3–5 employed or contracted SLPs beyond the owner, diversified payer mix, established referral relationships with schools or physicians, and a clean compliance history
Get Deal Flow In Your Inbox
New Speech Therapy Practice acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Speech Therapy Practice acquisition
Seller Intelligence
Who sells Speech Therapy Practice businesses?
Owner-operator SLPs nearing retirement, clinician-founders experiencing burnout, practice owners seeking liquidity after 10–20 years of growth, and owners wanting to exit day-to-day clinical management while retaining partial equity
Typical exit timeline: 12–24 months
Speech Therapy Practice businesses in the $1M–$5M revenue range typically sell for 3.5–6× EBITDA. Typically targeting practices with $1M–$5M in revenue, EBITDA margins of 15–30%, at least 3–5 employed or contracted SLPs beyond the owner, diversified payer mix, established referral relationships with schools or physicians, and a clean compliance history
Speech Therapy Practice businesses typically trade at 3.5–6× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Speech Therapy Practice businesses are SBA 7(a) eligible, making them accessible to first-time buyers. SBA 7(a) loan with 10–20% buyer equity, seller note for 5–10% with 2-year standby, and full cash-out at close
Key due diligence areas include: Payer mix analysis and reimbursement rate sustainability across insurance, private pay, and government programs; Clinician licensure verification, non-compete enforceability, and staff retention risk post-close; HIPAA compliance, EHR documentation quality, and billing audit history; Referral source concentration and durability of school district contracts or physician relationships; Owner clinical involvement — percentage of revenue tied to founder's personal caseload.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers